Bioinformatics analysis and RT‐PCR results show that the expression of ASPM is increased in HCC and is associated with poor prognosis in patients with HCC [21, 22], but its biological function and molecular mechanisms in HCC are still unknown. This evidence concerns the gene ASPM and hepatocellular carcinoma.